Richard S. Ginsberg
11Patents
10h-index
15Co-inventors
65Inventor score
Filing activity: Jul 26, 1984 → May 26, 1998
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4880635A | Dehydrated liposomes | Human Necessities | 199 | Expired |
| US5169637A | Stable plurilamellar vesicles | Emerging Cross-Sectional Technologies | 146 | Expired |
| US5030453A | Stable plurilamellar vesicles | Human Necessities | 102 | Expired |
| US5000958A | Enhancement of pharmaceutical activity | Emerging Cross-Sectional Technologies | 90 | Expired |
| US5795589A | Liposomal antineoplastic agent compositions | Emerging Cross-Sectional Technologies | 80 | Expired |
| US5922350A | Methods of dehydrating, storing and rehydrating liposomes | Human Necessities | 59 | Expired |
| US5578320A | Method of dehydrating liposomes using protective sugars | Human Necessities | 46 | Expired |
| US5616341A | High drug:lipid formulations of liposomal antineoplastic agents | Emerging Cross-Sectional Technologies | 46 | Expired |
| US5837279A | Encapsulation of ionizable agents in liposomes | Human Necessities | 38 | Expired |
| US6083530A | High drug:lipid formulations of liposomal-antineoplastic agents | Emerging Cross-Sectional Technologies | 17 | Expired |
| US5744158A | Methods of treatment using high drug-lipid formulations of liposomal-antineoplastic agents | Emerging Cross-Sectional Technologies | 9 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.